Low knowledge of HPV and its relation to cervical cancer [22–27]
|
Infrastructure and human resources [28–31]
|
Lack of political will [28,32–37]
|
Societal values and stigma [38–42]
|
Financing Mechanisms and Vaccine Cost [23,28,33,35,36,39,43–48]
|
Involvement and coordination of diverse stakeholders [13,35,43,49]
|
Parental concerns of side effects including (in)fertility, early sexual onset, increased sexual activity and vaccine safety [23,24,26,27,31,48,50]
|
Donation Programmes [36,40–42,51–54]
|
Competing health priorities and evidence-based decision-making [29,32–35,37–39,55,56]
|
Vaccine target age and group [26,29,42,57]
|
Reaching out-of-school girls [26,30,31,38,40,42,57,58]
|
|
Community sensitisation and advocacy [26,31,36,39,41,42,59,60]
|
Logistics and timetabling [28,60]
|
|
|
Delivery Strategies [30,31,38,40–42,57–61]
|
|